Abstract
Probiotic bacteria show promising results in prevention of the biofilm-mediated disease caries, but the mechanisms are not fully understood. The acid tolerance response (ATR) allows biofilm bacteria to survive and metabolize at low pH resulting from microbial carbohydrate fermentation. We have studied the effect of probiotic strains: Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus on ATR induction in common oral bacteria. Communities of L. reuteri ATCC PTA5289 and Streptoccus gordonii, Streptococcus oralis, Streptococcus mutans or Actinomyces naeslundii in the initial stages of biofilm formation were exposed to pH 5.5 to allow ATR induction, followed by a low pH challenge. Acid tolerance was evaluated as viable cells after staining with LIVE/DEAD®BacLight™. The presence of L. reuteri ATCC PTA5289 caused a significant reduction in acid tolerance in all strains except S. oralis. When S. mutans was used as a model organism to study the effects of additional probiotic strains (L. reuteri SD2112, L. reuteri DSM17938 or L. rhamnosus GG) as well as L. reuteri ATCC PTA5289 supernatant on ATR development, neither the other probiotic strains nor supernatants showed any effect. The presence of L. reuteri ATCC PTA5289 during ATR induction led to down-regulation of three key genes involved in tolerance of acid stress (luxS, brpA and ldh) in Streptococci. These data suggest that live cells of probiotic L. reuteri ATCC PTA5289 can interfere with ATR development in common oral bacteria and specific strains of L. reuteri may thus have a role in caries prevention by inhibiting development of an acid-tolerant biofilm microbiota.
Keywords: Probiotics, Acid tolerance, Caries, Early oral biofilms, Pioneer species
1. Introduction
Oral biofilms in health are usually highly diverse, with over 700 different bacterial species identified to date [1] and single individuals hosting 100–200 species [2]. Biofilm composition differs throughout the oral cavity due to variation in the ecological niches at different sites. The supragingival microbiota is dominated by facultative anaerobic, saccharolytic species belonging to the genera Streptococcus, Actinomyces, Veillonella, Granulicatella and Rothia whereas the subgingival microflora is often dominated by Gram-negative, anaerobic and proteolytic species [3,4]. The microbiota is important for maintaining oral health through prevention of colonization by exogenous pathogens, but is also the cause of the major biofilm-related diseases; caries and periodontitis. The ecological plaque hypothesis describes oral disease as arising from changes in the composition and/or properties of biofilms (dysbiosis) due to sustained environmental perturbations and any bacteria in the community with relevant traits can contribute to the disease process [5]. Thus, in contrast to previously favoured preventive measures such as elimination of bacteria, recent years have seen an increased focus on promoting oral health through maintenance of a balanced, eubiotic microbiome [6].
Probiotic bacteria have been defined by the Food and Agriculture Organization of the United Nations and the World Health Organization as “live microorganisms which, when administered in adequate amounts, confer a health benefit on the host” [7]. They have traditionally been used to treat infections in the gastrointestinal (GI) tract as well as for promoting a healthy gut microbiota [8]. The effects have been proposed to include immunomodulation and inhibition of pathogen growth, as well as the promotion of health-related bacteria [9,10]. Over recent decades, the effect of probiotics in the prevention and treatment of oral biofilm-mediated diseases has been investigated in a number of clinical studies. A systematic review including fifty studies revealed evidence that the administration of probiotics could significantly reduce the clinical signs of periodontal inflammation and supported their use for the management of periodontal disease [11]. Clinical trials on the prevention and treatment of dental caries have shown a reduction in caries activity in children after probiotic intervention with L. reuteri ATCC 55730 [12] or a combination of Streptococcus uberis KJ2™, Streptococcus oralis KJ3™ and Streptococcus rattus JH145™ [13], and administration of probiotic strains in a range of different vehicles has been shown to reduce counts of Streptococcus mutans in saliva [[14], [15], [16]]. These promising results are reinforced by a range of in vitro studies investigating the mechanisms of action of probiotic strains in the oral cavity. Limosilactobacillus reuteri strain ATCC PTA5289 has been shown to inhibit binding of S. mutans to saliva-coated surfaces [17] and a range of probiotic strains including L. reuteri ATCC PTA5289 and Lacticaseibacillus rhamnosus GG coaggregate with, and inhibit growth of, mutans streptococci [[18], [19], [20]]. More recently, challenge with cultures of live L. reuteri ATCC PTA5289, but not culture supernatants, has been demonstrated to reduce the cariogenic activity of in vitro biofilms [21] and addition of L. reuteri ATCC PTA5289 to a multispecies biofilm model significantly reduced S. mutans levels [22]. These results suggest that further investigation into potential mechanisms by which these probiotic strains could contribute to managing dental caries are warranted.
Bacterial carbohydrate fermentation by members of the oral biofilm results in acidic end-products such as lactic and acetic acids, which lower the pH in the biofilm and can lead to dissolution of tooth enamel and dentine [23]. The buffering capacity of the saliva as well as bacterial generation of alkaline end-products helps to neutralize this fall in pH, resulting in a dynamic balance between de- and remineralization of dental hard tissues [24]. However, frequent intake of readily fermentable carbohydrates will result in increased duration of low pH. These changes in the biofilm environment can lead to dysbiosis and alterations in composition, resulting in selection of bacteria with an acid-tolerant phenotype [5]. As low intracellular pH denatures proteins and inhibits metabolic processes, members of the oral biofilm have developed mechanisms to protect themselves from low external pH. The acidogenic species S. mutans, that can be isolated from cariogenic biofilms, has been shown to induce an acid tolerance response (ATR) when exposed to a sub-lethal pH [25], including upregulation of genes involved in regulation of intracellular pH and tolerance of acid stress (26, 27). In vitro the development of an ATR has been shown to include factors that could contribute to a caries-promoting microbiota in vivo, including enhanced ability to metabolize and carry out cellular functions at a lower pH, which is not seen in non-adapted cells [28]. It is therefore likely that the ATR is an important step in the development of an acid tolerant microbiota that promotes net hard tissue demineralization and development of caries. In S. mutans, cells adhered to a surface showed an increased acid tolerance, which is further enhanced after adaptation after only 4 h of biofilm growth, indicating an ability to induce an ATR during the initial stages of biofilm development [29]. Recently we have shown that other abundant members of oral biofilms, often associated with health, are also able to induce an ATR in the early stages of biofilm formation, indicating that they might play a role in caries initiation by driving the development of an acid tolerant microbiota [30]. Intervention in ATR induction could thus be an effective measure for the prevention of caries and the aim of this study was therefore to investigate the effect of probiotic strains of L. reuteri as well as one probiotic strain of L. rhamnosus on ATR induction in four oral strains of streptococci as well as Actinomyces.
2. Materials and methods
2.1. Bacterial strains and media
Four strains of oral streptococci were used in this study; a type culture strain of S. mutans UA159 (ATCC 700610) and three archived strains originally isolated from supragingival dental plaque of healthy individuals [S. mutans (B4B), Streptococcus gordonii (CW) and S. oralis (CW)]. Following isolation on blood agar, Gram-positive, catalase-negative, facultative anaerobic cocci growing in chains were identified using phenotypic tests [31,32], and their identities confirmed with 16 S rRNA sequencing (S. oralis) or PCR (S. mutans and S. gordonii). One strain of Actinomyces naeslundii (CW) was also used. This was isolated on blood agar from healthy supragingival plaque, as Gram-positive, facultative anaerobic branched rods and identified to species level using phenotypic tests [33] and PCR.
The probiotic bacteria used were: L. reuteri ATCC PTA5289 (FJ1; isolated from the oral cavity of a Japanese woman with no signs of oral disease), L. reuteri SD2112 (ATCC 55730; isolated from the breast milk of a Peruvian woman), L. reuteri DSM17938 (a daughter strain of L. reuteri SD2112 lacking the resistance plasmids against tetracycline and lincomycin) (BioGaia, Stockholm, Sweden) and L. rhamnosus GG ATCC 53103 (isolated from the intestinal tract of a healthy individual). Bacteria were inoculated separately into either Todd Hewitt Broth (oral strains) or MRS Broth (probiotic strains) and incubated at 37 °C in 5% CO2 overnight. Aliquots of the overnight cultures were grown to exponential growth phase (OD600 = 0.5–0.8) in fresh growth medium at 37 °C in 5% CO2. Minimal medium, MM4 [34] containing 20 mM glucose, buffered with 40 mM phosphate/citrate buffer at pH 3.5, 5.5 and 7.5 was used for the acid-tolerance response experiments.
2.1.1. Initial biofilm formation in mini flow-cell systems
Cultures of each strain in exponential growth phase (OD600 = 0.6–0.8) were transferred to MM4, pH 7.5 through two rounds of centrifugation at 2400×g, 5 °C, for 5 min (Thermo Scientific Heraeus Fresco 17 Centrifuge, Gothenburg, Sweden) and resuspension in MM4, pH 7.5. The effect on ATR induction was then investigated by inoculating a mixture of L. reuteri ATCC PTA5289 (50 μl) and an equal volume of S. gordonii, S. oralis, S. mutans (B4B or UA159) or A. naeslundii suspensions into mini flow-cells compatible with inverted confocal laser scanning microscopy (IbiTreat μ-Slide VI, Ibidi, Germany). The flow-cells were then incubated in a humid chamber in 5% CO2 at 37 °C for 2 h to allow the cells to attach and initiate biofilm formation. Single-species biofilms of S. gordonii, S. oralis, S. mutans (UA159, B4B), or A. naeslundii were initiated in the same manner by inoculating aliquots (100 μl) into the mini-flow cells and maintaining in a humid chamber in 5% CO2 at 37 °C for 2 h.
2.1.2. ATR development in oral strains
After 2 h, excess medium was removed and an ATR induced by exposing the bacterial cells to an adaptation pH, 5.5. Channels were gently washed twice with MM4 pH 5.5, fresh MM4 pH 5.5 added and the flow-cells incubated in a humid chamber for 2 h in 5% CO2 at 37 °C. Control cells (non-adapted) were washed with MM4 pH 7.5 and fresh MM4 pH 7.5 added for 2 h. After this period, acid tolerance development was assessed by subjecting control and adapted bacteria to a low pH challenge by washing twice with MM4 pH 3.5 and incubating with MM4 pH 3.5 for 30 min in 5% CO2 at 37 °C. Viability was then assessed by staining with LIVE/DEAD®BacLight™ stain (Molecular Probes, Eugene, Oregon, USA) according to manufacturer's instructions, and visualizing with confocal laser scanning microscopy (CLSM) using a Nikon Eclipse TE200 inverted microscope [35]. To confirm viability measurements from the BacLight assay, control cells in MM4 pH 7.5 and cells challenged with MM4 pH 3.5 for 30 min as above were plated onto blood agar and incubated at 37 °C in 5% CO2 for 48 h, after which the number of colony-forming units (CFU) was counted.
To ensure that the presence of L. reuteri ATCC PTA5289 did not affect viability of the oral strains during the adaptation period, an additional experiment was conducted where the cells were exposed to the adaptation pH (pH 5.5) in the presence of L. reuteri ATCC PTA5289 for 2 h followed by a further 30 min at pH 5.5. Viability was assessed as above.
2.1.3. Effects of other probiotic strains on acid tolerance development
To investigate whether other probiotic strains affected ATR induction, exponential growth phase cells of the model organism, S. mutans UA159 were inoculated into the mini flow-cells with equal volumes of L. reuteri SD2112, L. reuteri DSM17938 or L. rhamnosus GG and maintaining in a humid chamber in 5% CO2 at 37 °C for 2 h. Development of an ATR was then studied by subjecting control and adapted bacteria to a low pH challenge and assessing viability as above.
2.1.4. Collection of L. reuteri ATCC PTA5289-derived supernatant
L. reuteri ATCC PTA5289 were allowed to adhere to the surface of mini flow-cells for 2 h in MM4 pH 7.5. To maximize the concentration of L. reuteri-derived products in the supernatant, twice the number of cells were used compared to when L. reuteri was grown together with an oral strain. Following adaptation in MM4 pH 5.5 for a further 2 h and a low pH challenge of 30 min in MM4 pH 3.5, supernatants (130 μl) were collected and centrifuged (2400×g, 5 °C for 5 min). The pellet was then discarded and the pH of the supernatant adjusted to 7.5, 5.5 or 3.5 using HCl. Aliquots were stored at −20 °C until use.
2.1.5. ATR development in S. mutans UA159 during exposure to L. reuteri ATCC PTA5289-derived supernatant
Exponential growth phase cells of S. mutans UA159 washed in MM4 pH 7.5 were suspended in L. reuteri ATCC PTA5289-derived supernatant, pH 7.5 and inoculated into mini flow-cells which were kept in a humid chamber in 5% CO2 at 37 °C for 2 h. Following attachment, the medium was removed and lanes were washed twice with MM4 pH 5.5. L. reuteri-derived supernatant pH 5.5 was added to each lane and the flow-cells were incubated in a humid chamber with 5% CO2 at 37 °C. After 2 h of adaptation, the medium was removed and the flow-cells washed with MM4 pH 3.5. L. reuteri derived supernatant, pH 3.5 was added to each lane and incubated in a humid chamber with 5% CO2 at 37 °C for 30 min. Control cells were exposed to MM4 at the equivalent pH without the addition of the L. reuteri-derived supernatant. Viability was then assessed as described above.
2.2. Image- and statistical analysis
All experiments were performed in triplicate, using three independent biological replicates of each strain. For analysis of acid tolerance of the oral strains, images from ten areas of the biofilm (image area = 0.05 mm2), selected randomly using the Nikon NIS elements software, were captured and saved for subsequent analysis. The percentage of live cells was calculated after counting the green (live) and red (dead) cells in each image manually, while distinguishing between the strains on the basis of morphology (Fig. 1). All images were printed at high resolution and analyzed independently by four calibrated investigators. Mean values obtained were analyzed with the Mann-Whitney U test using Prism 9.3.1 software (GraphPad San Diego, USA). P-values of less than 0.05 were considered statistically significant.
Fig. 1.
Representative images of L. reuteri ATCC PTA5289 (blue arrow) in the initial stages of biofilm formation with S. mutans ATCC UA159 or A. naeslundii CW. Cells were exposed to pH 5.5 for 2 h, followed by exposure to pH 5.5 for a further 30 min (1 A and 1C) or a challenge of pH 3.5 for 30 min (1 B and 1D). They were then visualized with LIVE/DEAD®BacLight™ staining and CLSM. White arrows show live cells of S. mutans ATCC UA159 or A. naeslundii CW, and grey arrows show dead cells.
2.2.1. Effect of L. reuteri ATCC PTA5289 on the acid stress related gene expression of S. mutans ATCC UA159
Log phase suspensions (OD600 = 0.6–0.8) of S. mutans ATCC UA159 and L. reuteri ATCC PTA5289 were mixed and washed twice with MM4 pH 7.5 by centrifugation at 2400×g, at 5 °C for 5 min (Beckman Coulter GS-6R Centrifuge, California, USA). The cells were resuspended in MM4 pH 7.5 and inoculated in a Petri dish at 37 °C in 5% CO2 for 2 h to allow bacterial adhesion. The adhered cells were then washed three times with MM4 pH 5.5, resuspended in MM4 pH 5.5 and incubated at 37 °C in 5% CO2 for 2 h to allow bacterial adaptation. Excess medium was then discarded and bacterial cells were collected by scraping (Sarstedt, Newton, USA) and addition of new MM4 pH 5.5. The number of viable cells was determined as CFU after serial dilution in 10 mM phosphate-buffered saline and 0.07 M NaCl, pH 7,2 (PBS), and plating on blood agar. RNAprotectÒ Bacteria Reagent was added to the remaining bacterial suspensions followed by centrifugation at 2540×g, at 5 °C for 10 min. The supernatants were decanted and the pellets were stored at −80 °C for RNA Extraction. Single species biofilms of S. mutans ATCC UA159 were prepared and treated in the same manner. All experiments were carried out in triplicate using independent biological replicates.
2.2.2. RNA extraction, reverse transcriptase and quantitative RT-PCR
RNA was extracted using a Qiagen, RNeasy® Protect Bacteria kit (Hilden, Germany) according to the manufacturer's instructions, with the addition of 15 mg/ml lysozyme (62,971-10G-F, Sigma-Aldrich, Steinheim, Belgium) to the proteinase K/Tris-EDTA buffer followed by mechanical disruption with glass beads. Total RNA was quantified using a Qubit® RNA BR Assay Kit, Oregon, USA) and stored at −80 °C. Equal amounts of RNA were transcribed to cDNA using Superscript IV Vilo master mix containing ezDNase Enzyme according to the manufacturer's instructions (Thermo Fisher Scientific, California, USA). qPCR was carried out on a QuantStudio 3 (Applied Biosystems, Thermo Fisher Scientific, California, USA) using PowerTrack SYBRGreen master mix according to the manufacturer's instructions. The primers used are shown in Table 1. Values were normalized to the ratio of S. mutans CFU to the total CFU in the dual-species biofilms.
Table 1.
Primers used for qPCR [36].
| Primer | DNA sequence (5′ T 3′) | Length |
|---|---|---|
| luxS-Fw | ACTGTTCCCCTTTTGGCTGTC | 21 bp |
| luxS-Rv | AACTTGCTTTGATGACTGTGGC | 22 bp |
| brpA-Fw | CGTGAGGTCATCAGCAAGGTC | 21 bp |
| brpA-Rv | CGCTGTACCCCAAAAGTTTAGG | 22 bp |
| ldh-Fw | TTGGCGACGCTCTTGATCTTAG | 22 bp |
| ldh-Rv | GTCAGCATCCGCACAGTCTTC | 21 bp |
Fw = Forward, Rv = Reversed, T = To, bp = Base pair.
3. Results
3.1. L. reuteri ATCC PTA5289 inhibits ATR induction in oral bacteria
Dual species communities of L. reuteri ATCC PTA5289 and S. mutans, S. gordonii, S oralis or A. naeslundii in the initial stage of biofilm formation were created in mini flow-cells. After the 2 h adaptation period at pH 5.5, all of the oral strains as well as L. reuteri ATCC PTA5289 showed over 95% viability, as demonstrated by green staining with LIVE/DEAD® BacLight™ (Fig. 1A and C), and the oral strains represented 53–65% of the total cell count of the biofilms. The induction of acid-tolerance during the adaptation period was then evaluated by exposing the cells to a low pH challenge (pH 3.5) for 30 min (Fig. 1B and D). In the presence of L. reuteri ATCC PTA5289, the number of acid tolerant cells was significantly reduced in all strains except S. oralis, with the most prominent effect seen for S. mutans ATCC UA159, where there was an almost 3-fold reduction (p < 0.01, Fig. 2). The effect was similar, although less strong in S. mutans B4B and A. naeslundii, with a 2-fold decrease in the number of acid tolerant cells compared to control (p < 0.01, Fig. 2). For S. gordonii, there was also a significant decrease in the number of acid tolerant cells in the presence of L. reuteri ATCC PTA5289, although the effect was less pronounced than for the other bacteria [1.3-fold decrease (p < 0.01)]. Overall, these data show that the presence of L. reuteri ATCC PTA5289 significantly reduces development of an ATR in four of the five strains of oral bacteria tested.
Fig. 2.
Viability of oral streptococci and Actinomyces in initial biofilms alone or together with L. reuteri ATCC PTA5289 (+PTA5289). Cells were subjected to adaptation at pH 5.5 for 2 h followed by an acid challenge of pH 3.5 for 30 min. Viability was assessed using CLSM after staining with LIVE/DEAD® BacLight™. Percentage viability of oral strains was evaluated by counting the cells manually and graphs show the mean and standard deviation of three independent biological replicates, *P < 0.05.
3.2. Inhibition of ATR induction in S. mutans (UA159) by L. reuteri is strain-dependent
To test whether the effect seen on ATR development in the oral bacteria was specific to L. reuteri ATCC PTA5289, two additional strains of L. reuteri; L. reuteri DSM17938 and L. reuteri SD2112, as well as L. rhamnosus GG were tested. Since the effect of L. reuteri ATCC PTA5289 on ATR development was greatest for S. mutans UA159, this was used as a model organism in these experiments. In the control, containing only S. mutans UA159, 52% of the cells induced an ATR after exposure to pH 5.5 for 2 h and this was significantly reduced by the presence of L. reuteri ATCC PTA5289. However, no statistically significant reduction in the number of acid tolerant cells was seen in the presence of any of the other tested strains; L. reuteri DSM17938 (p = 0.153), L. reuteri SD2112 (p = 0.859) or L. rhamnosus GG (p = 0.265) (Fig. 3). These data thus show that, amongst the probiotic strains tested here, the inhibitory effect on ATR development was specific to L. reuteri ATCC PTA5289.
Fig. 3.
Viability of S. mutans ATCC UA159 in the initial stages of biofilm formation with L. reuteri strains: ATCC PTA5289 (+PTA5289), DSM17938 (+DSM17938) and SD2112 (+SD2112), L. rhamnosus strain GG (+GG) or L. reuteri ATCC PTA5289-derived supernatant (+PTA5289 S). Percent viability of S. mutans cells when grown together with the probiotic strains or supernatant is presented as relative to the viability of single-species initial biofilms of S. mutans ATCC UA159. The cells were exposed to pH 5.5 for 2 h followed by an acid challenge at pH 3.5 for 30 min. Viability was assessed with LIVE/DEAD® BacLight™ staining and CLSM. Percentage viability of cells was evaluated by counting manually and graphs show the mean and standard deviation of three independent biological replicates, *P < 0.05.
3.3. Supernatants of L. reuteri ATCC PTA5289 do not affect bacterial adhesion or ATR induction
To further investigate their effect on ATR induction, supernatants of sessile L. reuteri ATCC PTA5289 cells were prepared and their effects on the initial stages of biofilm formation and ATR induction tested in S. mutans UA159. The concentration of L. reuteri-derived products in the supernatant was optimized by increasing the cell number. Adhesion to the flow-cell surfaces was not affected by the L. reuteri supernatant with a mean surface coverage of 57% (SEM ± 3.5%) in the control and 54% (SEM ± 6.1%) in the presence of the supernatant. After exposure to pH 5.5 for 2 h followed by a low pH challenge (pH 3.5) for 30 min, surface coverage in the presence of the L. reuteri supernatant did not differ from control (p = 0.245). A somewhat lower surface coverage was seen after exposure to pH 3.5 compared to pH 7.5 and 5.5 respectively, but this was the same for both conditions. In contrast to when L. reuteri ATCC PTA5289 was physically present, the supernatant had no effect on ATR development, with these cells showing a small significant increase in survival at pH 3.5 (Fig. 3).
3.4. L. reuteri ATCC PTA5289 causes a reduction in expression of luxS, brpA and ldh in S. mutans UA159
To investigate the effects of L. reuteri ATCC PTA5289 on acid tolerance at the cellular level, expression of three genes associated with the response to acid stress (luxS, brpA and ldh), was investigated in S. mutans UA159. This showed that expression levels of luxS, brpA and ldh were significantly reduced (14-fold, 5-fold and 15-fold, respectively) in S. mutans in the presence of L. reuteri ATCC PTA5289 compared to when S. mutans was grown alone (Fig. 4).
Fig. 4.
qPCR analysis of luxS, brpA and ldh expression in S. mutans ATCC UA159 during the initial stages of biofilm formation in the presence or absence of L. reuteri ATCC PTA5289. The effect of L. reuteri is presented as relative to S. mutans alone in the same experiment (n = 3, * = p < 0.05, *** = p < 0.001).
4. Discussion
In recent years, interest in promotion of a healthy oral microbiome and prevention of disease through the use of probiotic bacteria has increased. In caries, the ecological plaque hypothesis and its modification, propose that changes in the biofilm environment cause enrichment of aciduric and acid tolerant bacterial species, leading to a low pH environment which pushes the re-/demineralization balance at the hard tissue surface towards net demineralization [4,24]. We have shown that several bacterial species abundant in the healthy oral biofilm induce an ATR when exposed to a moderate change in environmental pH [30] and that the effect occurs rapidly following attachment to a surface [35]. Therefore, in this study we investigated whether probiotic bacteria could inhibit ATR induction during the initial stages of biofilm formation. The main finding was that L. reuteri ATCC PTA5289 had a significant inhibitory effect in all the bacteria that induced an ATR, while one strain of S. oralis which was already highly acid tolerant and did not induce an ATR, was unaffected. This is in keeping with previous studies of this strain of S. oralis (CW), which showed a high level of inherent acid tolerance which was not increased further by acid adaptation [30]. The inhibition was most prominent for the two S. mutans strains tested, but was also seen in S. gordonii and A. naeslundii. The phenotypic changes accompanying ATR development include an increased ability to survive and metabolize at low pH [25], resulting in an increased capacity for acid production even when the biofilm pH is low. Data from other in vitro studies show that L. reuteri ATCC PTA5289 can reduce lactic acid production in both single-species S. mutans biofilms and biofilms containing both S. mutans and A. naeslundii [21,37] and a recent clinical study revealed that daily intake of L. reuteri strains ATCC PTA5289 and DSM 17938 for three weeks led to a significant reduction in plaque acidogenicity in response to a 1-min mouth rinse with 10% sucrose [38]. Although not investigated here, our results suggest that inhibition of ATR development in common oral bacteria in the presence of L. reuteri ATCC PTA5289 could contribute to this effect.
To shed light on possible mechanisms by which L. reuteri PTA5289 exerted an inhibitory effect on ATR development, we investigated the expression of three key genes known to be involved in acid tolerance in S. mutans (luxS, a global regulator of cellular function [26], brpA [39], and ldh [27]) during ATR induction in the presence and absence of L. reuteri ATCC PTA5289. The results showed a significant down-regulation of all three genes compared to when an ATR was induced in S. mutans alone. This indicates that L. reuteri ATCC PTA5289 exerts an effect on acid tolerance through pathways involved in maintenance of intracellular pH and acid stress adaptation in S. mutans.
The effect of L. reuteri ATCC PTA5289 seen in this study was associated with the presence of live bacteria and could not be reproduced using supernatants even when the number of L. reuteri cells was doubled. Supernatants from L. reuteri ATCC PTA5289 have been shown to inhibit growth of S. mutans, possibly through production of H2O2 [37]. However, our findings are consistent with other studies showing that the physical presence of L. reuteri had an effect on biofilm pH and enamel demineralization that was not obtained using culture supernatants [21] and that a whole culture of L. reuteri ATCC 23272 had greater inhibitory effect on growth of S. mutans than spent medium [38].
Since the inhibitory effect on ATR development by L. reuteri PTA5289 was greatest in this strain, S. mutans UA159 was used to test the effects of other probiotic bacteria. L. rhamnosus GG, isolated from the human gastrointestinal tract, is one of the most widely used probiotic bacteria and has shown health effects, including prevention and treatment of gastro-intestinal infections and diarrhea, and stimulation of immune responses during vaccination [40]. However, in keeping a clinical investigation showing that short-term consumption of L. rhamnosus GG had no effect on plaque acid production [41], no effect on ATR development was seen in this study. This strain has, however, been demonstrated to reduce caries experience after long-term consumption and lower mutans streptococci counts in plaque and saliva in vivo [42] as well as inhibiting S. mutans biofilm formation in vitro; an effect that has been ascribed to a decrease in expression of glucosyltransferase and consequent reduction in glucan production [43,44].
Interestingly, the breast milk-derived L. reuteri strains; SD2112 and DSM 17938 (a plasmid-cured version of SD2112), which have similar attributes [45], also lacked the effect on ATR development in S. mutans UA159 seen for strain ATCC PTA5289. Since previous studies have demonstrated that strains ATCC PTA5289 and DSM17938 are similar in their capacity to generate a number of substances associated with probiotic effects, including H2O2 [46] and ammonia [47] these substances may not underlie the differential effect seen here. However, further investigations using for instance a peroxidase to quench H2O2 and a buffer to neutralize ammonia would be required to exclude these mechanisms. Multilocus sequence analysis (MLSA) has revealed that human-derived L. reuteri strains belong to two different multilocus sequence types [48] with strain ATCC PTA5289 (under its original designation, FJ1) assigned to clade II and strains SD2112 and DSM 17938 to clade VI [49]. Comparison of other probiotic features of these two clades reveal significant differences, for instance, in the production of the antimicrobial substance, reuterin [49]. However, glycerol was not present in the growth medium in the studies and during stationary phase growth (which can be related to biofilm growth) SD2112 and DSM 17938 produce significantly more reuterin than ATCC PTA5289 [50]. In addition, since an antimicrobial substance such as reuterin would be expected to affect viability of the oral strains independent of pH, and in this study all the oral strains showed a high viability at pH 7.5 and pH 5.5, a major role for this substance in the effect appears unlikely. This is in agreement with a recent investigation which revealed that L. reuteri ATCC PTA5289 exerts probiotic effects on streptococci that are independent of reuterin [22].
5. Conclusion
The results of this study thus show that the presence of L. reuteri ATCC PTA 5289 can inhibit the development of an ATR in the initial stages of biofilm formation in common oral bacteria. The effect is strain-specific and involves down-regulation of key genes involved in maintenance of intracellular pH and acid stress adaptation in streptococci. Specific strains of L. reuteri may thus have a role to play in caries prevention by inhibiting development of an acid tolerant biofilm microbiota.
Funding
This work was supported by The Foundation for Odontological Research in Malmö, The Foresight Research Programme, and Biofilms – Research Center for Biointerfaces at Malmö University, Malmö, Sweden.
Availability of data and materials
All data analyzed in this study are included in this published article in the form of tables and figures.
Competing interests
The authors declare that they have no competing interests.
Credit Author Statement
Gabriella Boisen: Conceptualization, Investigation, Data curation, Writing, Reviewing and Editing, Zdenka Prgomet: Investigation, Data curation, Writing, Reviewing and Editing, Hanna Dahl: Investigation, Data curation, Writing, Cindy Mkadmi: Investigation, Data curation, Writing, Gabriela Enggren: Conceptualization, Writing, Reviewing and Editing, Julia Davies: Conceptualization, Data curation, Writing, Reviewing and Editing.
Declaration of competing interest
The authors declare that they have no competing interests.
Acknowledgments
We thank Francesca Jönsson for help with method development.
Data availability
Data will be made available on request.
References
- 1.Verma D., Garg P.K., Dubey A.K. Insights into the human oral microbiome. Arch Microbiol. 2018;200:525–540. doi: 10.1007/s00203-018-1505-3. [DOI] [PubMed] [Google Scholar]
- 2.Dewhirst F.E., Chen T., Izard J., Paster B.J., Tanner A.C., Yu W.H., Lakshmanan A., Wade W.G. The human oral microbiome. J Bacteriol. 2010;192:5002–5017. doi: 10.1128/JB.00542-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sanz M., Beighton D., Curtis M.A., Cury J.A., Dige I., Dommisch H., Ellwood R., Giacaman R.A., Herrera D., Herzberg M.C., Könönen E., Marsh P.D., Meyle J., Mira A., Molina A., Mombelli A., Quirynen M., Reynolds E.C., Shapira L., Zaura E. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the Joint EFP/ORCA workshop on the boundaries between caries and periodontal disease. J Clin Periodontol. 2017;44:5–11. doi: 10.1111/jcpe.12682. [DOI] [PubMed] [Google Scholar]
- 4.Caselli E., Fabbri C., D'Accolti M., et al. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture. BMC Microbiol. 2020;20(1):120. doi: 10.1186/s12866-020-01801-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Marsh P.D. Are dental diseases example of ecological catastrophes? Microbiol. 2003;149:279–294. doi: 10.1099/mic.0.26082-0. [DOI] [PubMed] [Google Scholar]
- 6.Takahashi N., Nyvad B. Caries ecology revisited: microbial dynamics and the caries process. Caries Res. 2008;42:409–418. doi: 10.1159/000159604. [DOI] [PubMed] [Google Scholar]
- 7.Hill C., Guarner F., Reid G., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506–514. doi: 10.1038/nrgastro.2014.66. [DOI] [PubMed] [Google Scholar]
- 8.Quigley E.M. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults. Nutr Clin Pract. 2012;27(2):195–200. doi: 10.1177/0884533611423926. [DOI] [PubMed] [Google Scholar]
- 9.Lebeer S., Vanderleyden J., De Keersmaecker S.C. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev. 2007;2:728–764. doi: 10.1128/MMBR.00017-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Rondanelli M., Faliva M.A., Perna S., Giacosa A., Peroni G., Castellazzi A.M. Using probiotics in clinical practice: where are we now? A review of existing meta-analyses. Gut Microb. 2017;8:521–543. doi: 10.1080/19490976.2017.1345414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Gruner D., Paris S., Schwendicke F. Probiotics for managing caries and periodontitis: systematic review and meta-analysis. J Dent. 2016;48:16–25. doi: 10.1016/j.jdent.2016.03.002. [DOI] [PubMed] [Google Scholar]
- 12.Stensson M., Koch G., Coric S., Abrahamsson T.R., Jenmalm M.C., Birkhed D., Wendt L.K. Oral administration of Lactobacillus reuteri during the first year of life reduces caries prevalence in the primary dentition at 9 years of age. Caries Res. 2014;48:111–117. doi: 10.1159/000354412. [DOI] [PubMed] [Google Scholar]
- 13.Hedayati-Hajikand T., Lundberg U., Eldh C., Twetman S. Effect of probiotic chewing tablets on early childhood caries: a randomized controlled trial. BMC Oral Health. 2015;15:112. doi: 10.1186/s12903-015-0096-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Laleman I., Detailleur V., Slot D.E., Slomka V., Quirynen M., Teughels W. Probiotics reduce mutans streptococci counts in humans: a systematic review and meta-analysis. Clin Oral Invest. 2014;18:1539–1552. doi: 10.1007/s00784-014-1228-z. [DOI] [PubMed] [Google Scholar]
- 15.Alforaidi S., Bresin A., Almosa N., Lehrkinder A., Lingström P. Oral colonisation after the administration of drops containing Lactobacillus reuteri. Oral Health Prev Dent. 2020;18:1017–1023. doi: 10.3290/j.ohpd.a45523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Romani Vestman N., Hasslöf P., Keller M.K., Granström E., Roos S., Twetman S., Stecksén-Blicks C. Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial. Caries Res. 2013;47:338–345. doi: 10.1159/000347233. [DOI] [PubMed] [Google Scholar]
- 17.Marttinen A., Haukioja A.L., Keskin M., Söderling E.M. Effects of Lactobacillus reuteri PTA5289 and L. paracasei DSMZ16671 on adhesion and biofilm formation of Streptococcus mutans. Curr Microbiol. 2013;67:193–199. doi: 10.1007/s00284-013-0352-3. [DOI] [PubMed] [Google Scholar]
- 18.Twetman L., Larsen U., Fiehn N.E., Stecksen-Blicks C., Twetman S. Coaggregation between probiotic bacteria and caries-associated strains: an in vitro study. Acta Odontol Scand. 2009;67:284–288. doi: 10.1080/00016350902984237. [DOI] [PubMed] [Google Scholar]
- 19.Hasslöf P., Hedberg M., Twetman S., Stecksen-Blicks C. Growth inhibition of oral mutans streptococci and Candida by commercial probiotic lactobacilli--an in vitro study. BMC Oral Health. 2010 Jul 2;10:18. doi: 10.1186/1472-6831-10-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Keller M.K., Hasslof P., Stecksen-Blicks C., Twetman S. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study. Acta Odontol Scand. 2011;69:263–268. doi: 10.3109/00016357.2011.554863. [DOI] [PubMed] [Google Scholar]
- 21.Chen Z., Schlafer S., Göstemeyer G., Schwendicke F. Probiotic effects on multispecies biofilm composition, architecture, and caries activity in vitro. Microorganisms. 2020 Aug 21;8:1272. doi: 10.3390/microorganisms8091272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Van Holm W., Verspecht T., Carvalho R., et al. Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: a synergistic synbiotic approach. Mol Oral Microbiol. 2022;37(6):266–275. doi: 10.1111/omi.12386. [DOI] [PubMed] [Google Scholar]
- 23.Carlsson J., Hamilton I.R. In: Textbook of clinical cariology. second ed. Thylstrup A., Fejerskov O., editors. Munksgaard; Copenhagen, Denmark: 1994. Metabolic activities of oral bacteria; pp. 71–110. [Google Scholar]
- 24.Fejerskov O., Nyvad B., Kidd E.A.M. In: Dental caries. second ed. Fejerskov O., Kidd E., editors. Blackwell Munksgaard; Oxford, United Kingdom: 2008. Pathology of dental caries; pp. 19–48. [Google Scholar]
- 25.Svensäter G., Larsson U.B., Greif E.C.G., Cvitkovitch D.G., Hamilton I.R. Acid tolerance response and survival by oral bacteria. Oral Microbiol Immunol. 1997;12:266–273. doi: 10.1111/j.1399-302x.1997.tb00390.x. [DOI] [PubMed] [Google Scholar]
- 26.Wen Z.T., Burne R.A. LuxS mediated signaling in Streptococcus mutans is involved in regulation of acid and oxidative stress tolerance and biofilm formation. J Bacteriol. 2004;186:2682–2691. doi: 10.1128/JB.186.9.2682-2691.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Welin J., Wilkins J.C., Beighton D., et al. Effect of acid shock on protein expression by biofilm cells of Streptococcus mutans. FEMS Microbiol Lett. 2003;227(2):287–293. doi: 10.1016/S0378-1097(03)00693-1. [DOI] [PubMed] [Google Scholar]
- 28.McNeill K., Hamilton I.R. Effect of acid stress on the physiology of biofilm cells of Streptococcus mutans. Microbiology. 2004;150:735–742. doi: 10.1099/mic.0.26482-0. [DOI] [PubMed] [Google Scholar]
- 29.Welin-Neilands J., Svensater G. Acid tolerance of biofilm cells of Streptococcus mutans. Appl Environ Microbiol. 2007;73(17):5633–5638. doi: 10.1128/AEM.01049-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Boisen G., Davies J.R., Neilands J. Acid tolerance in early colonizers of oral biofilms. BMC Microbiol. 2021;21:45. doi: 10.1186/s12866-021-02089-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Beighton D., Hardie J.M., Whiley R.A. A scheme for the identification of viridans streptococci. J Med Microbiol. 1991;35:367–372. doi: 10.1099/00222615-35-6-367. [DOI] [PubMed] [Google Scholar]
- 32.Whiley R.A., Beighton D. Current classification of the oral streptococci. Oral Microbiol Immunol. 1998;13:195–216. doi: 10.1111/j.1399-302x.1998.tb00698.x. [DOI] [PubMed] [Google Scholar]
- 33.Sarkonen N., Könönen E., Summanen P., Könönen M., Jousimies-Somer H. Phenotypic identification of Actinomyces and related species isolated from human sources. J Clin Microbiol. 2001:3955–3961. doi: 10.1128/JCM.39.11.3955-3961.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hamilton I.R., Svensater G. Acid-regulated proteins induced by Streptococcus mutans and other oral bacteria during acid shock. Oral Microbiol Immunol. 1998;13:292–300. doi: 10.1111/j.1399-302x.1998.tb00710.x. [DOI] [PubMed] [Google Scholar]
- 35.Welin-Neilands J., Svensater G. Acid tolerance of biofilm cells of Streptococcus mutans. Appl Environ Microbiol. 2007;73:5633–5638. doi: 10.1128/AEM.01049-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wen Z.T., Yates D., Ahn S.J., Burne R.A. Biofilm formation and virulence expression by Streptococcus mutans are altered when grown in dual-species model. BMC Microbiol. 2010;10:111. doi: 10.1186/1471-2180-10-111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Yu H., Ganas P., Schwendicke F. Environment-specific probiotic supernatants modify the metabolic activity and survival of Streptococcus mutans in vitro. Front Microbiol. 2020 Jun 26;11:1447. doi: 10.3389/fmicb.2020.01447. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Alforaidi S., Bresin A., Almosa N., Lehrkinder A., Lingström P. Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA5289) on plaque acidogenicity and other caries-related variables in orthodontic patients. BMC Microbiol. 2021 Oct 6;21(1):271. doi: 10.1186/s12866-021-02310-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wen Z.T., Baker H.V., Burne R.A. Influence of BrpA on critical virulence attributes of Streptococcus mutans. J Bacteriol. 2006;188(8):2983–2992. doi: 10.1128/JB.188.8.2983-2992.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Segers M.E., Lebeer S. Towards a better understanding of Lactobacillus rhamnosus GG – host interactions. Microb Cell Factories. 2014;13(Suppl 1):S7. doi: 10.1186/1475-2859-13-S1-S7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Marttinen A., Haukioja A., Karjalainen S., Nylund L., Satokari R., Öhman C., Holgersson P., Twetman S., Söderling E. Short-term consumption of probiotic lactobacilli has no effect on acid production of supragingival plaque. Clin Oral Invest. 2012;16:797–803. doi: 10.1007/s00784-011-0584-1. [DOI] [PubMed] [Google Scholar]
- 42.Näse L., Hatakka K., Savilahti E., Saxelin M., Pönkä A., Poussa T., Korpela R., Meurman J.H. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res. 2001;35:412–420. doi: 10.1159/000047484. [DOI] [PubMed] [Google Scholar]
- 43.Lee S.H., Kim Y.J. A comparative study of the effect of probiotics on cariogenic biofilm model for preventing dental caries. Arch Microbiol. 2014;196:601–609. doi: 10.1007/s00203-014-0998-7. [DOI] [PubMed] [Google Scholar]
- 44.Söderling E.M., Marttinen A.M., Haukioja A.L. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro. Curr Microbiol. 2011;62:618–622. doi: 10.1007/s00284-010-9752-9. [DOI] [PubMed] [Google Scholar]
- 45.Rosander A., Connolly E., Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74:6032–6040. doi: 10.1128/AEM.00991-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Jorgensen M.R., Kragelund C., Jensen P.O., Keller M.K., Twetman S. Probiotic Lactobacillus reuteri has antifungal effects on oral Candida species in vitro. J Oral Microbiol. 2017;9(1) doi: 10.1080/20002297.2016.1274582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Jalasvuori H., Haukioja A., Tenovuo J. Probiotic Lactobacillus reuteri strains ATCC PTA5289 and ATCC 55730 differ in their cariogenic properties in vitro. Arch Oral Biol. 2012;57:1633–1638. doi: 10.1016/j.archoralbio.2012.07.014. [DOI] [PubMed] [Google Scholar]
- 48.Oh P.K., Benson A.K., Peterson D.A., Patil P.B., Moriyama E.N., Roos S., Walter J. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution. ISME J. 2010;4:377–387. doi: 10.1038/ismej.2009.123. [DOI] [PubMed] [Google Scholar]
- 49.Spinler J., Sontakke A., Hollister E.B., Venable S.F., Oh P.L., Balderas M.A., Saulnier D.M.A., Mistretta T.-A., Devaraj S., Walter J., Versalovic J., Highlander S.K. From prediction to function using evolutionary genomics: human-specific ecotypes of Lactobacillus reuteri have diverse probiotic functions. Genome Biol Evol. 2014;6:1772–1789. doi: 10.1093/gbe/evu137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Spinler J.K., Taweechotipatr M., Rognerud C.L., Ou C.N., Tumwasorn S., Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008;14:166–171. doi: 10.1016/j.anaerobe.2008.02.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data analyzed in this study are included in this published article in the form of tables and figures.
Data will be made available on request.




